Clinical Trial Update: Fludarabine/Busulfan and Cyclophosphamide Conditioning for Adult Lymphoid Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating fludarabine/busulfan and cyclophosphamide conditioning for adult lymphoid malignancies has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoid Malignancies

Drugs mentioned

• Fludarabine/Busulfan and Cyclophosphamide conditioning

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Lymphoid Malignancies | Phase 2 | Status: COMPLETED